Abundant Ventures

Abundant Ventures, founded in 2002 and based in Metamora, Michigan, is a venture capital investment firm that focuses on providing tailored financing solutions to businesses across various sectors, including manufacturing, construction, distribution, technology, healthcare, real estate, and services. The firm aims to maximize growth and profitability while minimizing risk through a range of financial products such as asset-based lending, accounts receivable financing, and private equity funding. Abundant Ventures also offers strategic business solutions, including business plan development, mergers and acquisitions assistance, and turnaround restructuring. By integrating their services with existing business operations, they help clients increase working capital, secure commercial credit lines, and navigate seasonal funding challenges. The firm is dedicated to fostering partnerships and leveraging proven business practices to drive sustainable growth for its clients.

Frank Migliore

CEO

1 past transactions

HealthFinch

Series A in 2016
Healthfinch, Inc. is a healthcare IT company based in Madison, Wisconsin, founded in 2011. It specializes in developing technology aimed at streamlining prescription renewal requests and other routine clinical tasks for health systems. The company's flagship offering, the Charlie Practice Automation Platform, utilizes electronic medical record (EMR) data to automate and simplify workflows related to prescription refills, visit planning, and management of diagnostic results. By integrating seamlessly with major EMR systems such as Allscripts, Epic, and athena, Healthfinch's solutions enhance the efficiency of clinics and healthcare providers by reducing the burden of repetitive tasks, thereby allowing healthcare professionals to focus more on patient care. As of July 31, 2020, Healthfinch operates as a subsidiary of Health Catalyst, Inc.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.